Avalon (ALBT) GloboCare announced the renewal of the U.S. Food and Drug Administration, FDA, establishment registration for the KetoAir device by Qi Diagnostics Limited, a nanosensor-based diagnostic technologies company. Avalon markets and distributes the KetoAir device, a handheld breathalyzer designed for ketogenic health management which is registered with the U.S. Food and Drug Administration under registration number 3026284320
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALBT:
- Avalon GloboCare Regains Nasdaq Compliance, Strengthens Listing Status
- Avalon regains compliance with Nasdaq stockholders’ equity rule
- Avalon GloboCare Shareholders Elect Directors, Ratify Auditor
- Avalon GloboCare highlights RPM AI video platform integration
- Avalon GloboCare Acquires RPM Interactive for $19.5 Million
